ARHGDIB and Familial prostate cancer: Additionally, we show here that transcriptional co-repressor CtBP1, which has been shown to repress LCN2 (Lipocalin-2) and ARHGDIB (Rho GDP Dissociation Inhibitor Beta) expression in prostate cancer [16], regulates miR-124 expression.